Skip to main content
SpringerLink
Log in

Antibodies to NMDA receptor, blood–brain barrier disruption and schizophrenia: a theory with unproven links

  • Letter to the Editor
  • Published:
Molecular Psychiatry Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M et al. Mol Psychiatry advance online publication, 3 September 2013; doi:10.1038/mp.2013.110 (e-pub ahead of print).

  2. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R et al. J Neurosci 2010; 30: 5866–5875.

    Article  CAS  Google Scholar 

  3. Moscato E, Peng XY, Parsons T, Dalmau J, Balice-Gordon R . J Neuroimmunol 2012; 253: 145 (abstract 408).

    Google Scholar 

  4. Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein HG, Vielhaber S et al. JAMA Psychiatry 2013; 70: 271–278.

    Article  Google Scholar 

  5. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F et al. Lancet Neurol 2013; 13: 167–177.

    Article  Google Scholar 

Download references

Acknowledgements

Dr Titulaer is supported by grants from the Netherlands Organisation for Scientific Research (NWO, Veni-incentive), the Dutch Epilepsy Foundations (project number 14–19), an ErasmusMC fellowship and previously a clinical research fellowship by the Dutch Cancer Society (2009–4451). Dr Dalmau is supported by grants from the National Institutes of Health RO1NS077851, Fundació la Marató TV3 and Fondo de Investigaciones Sanitarias (FIS, PI11/01780).

Author information

Authors and Affiliations

  1. Department of Neurology at Hospital Clinic—Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

    M J Titulaer & J Dalmau

  2. Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands,

    M J Titulaer

  3. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

    J Dalmau

Authors
  1. M J Titulaer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Dalmau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Dalmau.

Ethics declarations

Competing interests

Dr Dalmau holds a patent application for the use of NMDA receptor as antibody test, and has received a research grant for Euroimmun. Dr Titulaer received a travel grant for lecturing in India from Sun Pharma, India.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Titulaer, M., Dalmau, J. Antibodies to NMDA receptor, blood–brain barrier disruption and schizophrenia: a theory with unproven links. Mol Psychiatry 19, 1054 (2014). https://doi.org/10.1038/mp.2014.25

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2014.25

  • Springer Nature Limited

This article is cited by

Search

Navigation